Quest Pharmatech Inc V.QPT

Alternate Symbol(s): QPTFF

Healthcare Biotechnology

Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest Inc., which is a biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest Inc.’s technology platform includes a panel of tumor antigen specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent, which is developing antibody-based immunotherapeutic products for cancer in the Greater China territory.

TSXV:QPT - Post by User

Quest Pharmatech Inc > Overvalued?

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jun 04, 2020 7:01pm

205 Views

Post# 31114098

RE:Overvalued?

New info received so recalc......

	Redeemable bonds
Gross proceeds	62,500,000	Usd
Tax & trans. costs	-12,500,000	Usd
Net proceeds	50,000,000	Usd
40% ownership	20,000,000	Usd
Per sh	$0.11	Usd
Fx	1.35
Per sh	$0.14	Cdn

lscfa wrote: Trading above cash from putable bonds...

Dec20/19

Shs

167,747,247

Options

18,600,000

186,347,247

Redeemable bonds

62,500,000

Usd

43% ownership

26,875,000

Usd

Per sh

$0.14

Usd

Fx

1.35

Per sh

$0.19

Cdn